Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2012
03/21/2012CN102379874A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
03/21/2012CN102379870A Preparation method of metronidazole clotrimazole and chlorhexidine acetate vaginal effervescent tablet
03/21/2012CN102379863A Application of flavaspidic acid AB to preparation of antitumor and antivirus medicament
03/21/2012CN102379853A Vidarabine monophosphate freeze-dried powder injection and preparation method thereof
03/21/2012CN102379842A Preparation method for fleroxacin injection
03/21/2012CN102379841A Preparation method of furacilin solution
03/21/2012CN102379839A Preparation method of salicylic acid ointment
03/21/2012CN102379833A Anti-bacterium hand cream made of traditional Chinese medicines
03/21/2012CN102379830A Chinese herbal medicine toothpaste
03/21/2012CN102379827A Toothpaste containing dencichine and preparation method thereof
03/21/2012CN102166280B Chinese medicinal composition for preventing and treating common cold and influenza and preparation method thereof
03/21/2012CN102133372B Compound peppermint oil preparation and effects thereof
03/21/2012CN102091073B Ceftazidime and tazobactam sodium medicine composition liposome injection
03/21/2012CN102091064B Use of furanodiene
03/21/2012CN102085251B Medicinal composition for treating hepatitis
03/21/2012CN102079750B Cefuroxime sodium compound and new preparation method thereof
03/21/2012CN101991519B Bacteriostatic lotion and preparation method thereof
03/21/2012CN101972320B Method for extracting ferulic acid, chlorogenic acid and other aicd components from coptis chinensis franch
03/21/2012CN101953841B Swine eperythrozoonosis-resisting compound long-acting oxytetracycline injection and preparation method thereof
03/21/2012CN101874838B Medicament for treating hepatitis B, cirrhosis and hepatic ascites
03/21/2012CN101849946B Composition of cefapirin sodium and tazobactam sodium and ratio of cefapirin sodium to tazobactam sodium
03/21/2012CN101822678B Cefamandole nafate combined drug
03/21/2012CN101757265B Traditional Chinese medicine composition for treating persistent hepatitis and preparation method thereof
03/21/2012CN101757074B Chewable tablet prepared from berberis
03/21/2012CN101744782B Tablet containing faropenem sodium
03/21/2012CN101716341B Human diploid cell inactivated rabies vaccine and preparation method thereof
03/21/2012CN101704886B Human alpha-defensin 5 antiviral active mutant polypeptide and preparation method and application
03/21/2012CN101584747B Antibacterial antivirus Chinese medicinal composition for animal
03/21/2012CN101555283B Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
03/21/2012CN101537138B Traditional Chinese medicine hepatitis B powder for eliminating duplication of hepatitis B virus (HBV) and method for manufacturing same
03/21/2012CN101513402B Antiviral agent
03/21/2012CN101503462B Method for removing endotoxin in influenza virus stock solution
03/21/2012CN101416936B Preparation method of long-acting composite sulfamonomethoxine suspension
03/21/2012CN101381757B Solid fermentation preparation method of antibacterial peptide and application
03/21/2012CN101249138B Schisandra chinensis ethyl hydrate extract and uses thereof, and anti AIDS pharmaceutical combination
03/21/2012CN101168564B Human antibiotic peptide and use for derivative thereof
03/21/2012CN101164543B Acyl pseudopeptides bearing a functionalised auxiliary spacer
03/21/2012CN101130071B Vaccine
03/21/2012CN101085069B Medicine for curing beriberi
03/21/2012CN101048502B Modified human hepatitis c virus genomic RNA having autonomous replicative competence
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138314 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
03/20/2012US8138200 Compositions and methods for double-targeting virus infections and targeting cancer cells
03/20/2012US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta
03/20/2012US8138172 8-oxoadenine derivatives acting as modulators of TLR7
03/20/2012US8138171 Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors
03/20/2012US8138164 HCV NS3 protease inhibitors
03/20/2012US8138155 Compounds for intracellular delivery of therapeutic moieties to nerve cells
03/20/2012US8138144 Antimicrobial cationic peptides and formulations thereof
03/20/2012US8138141 HMG1 antibody for treating inflammatory conditions
03/20/2012US8137705 Antimicrobial formulation comprising lactic acid and acidic calcium sulfate with caprylic acid, sodium benzoate, butyric acid and/or chlorine dioxide.
03/20/2012US8137682 Fibronectins; inflammation
03/20/2012US8137681 Polyanionic polymer adjuvants for Haemophilus influenzae B saccharide vaccines
03/20/2012CA2628131C Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
03/20/2012CA2493225C Quinoline derivatives and their use as mycobacterial inhibitors
03/20/2012CA2474801C Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
03/20/2012CA2453300C Chimeric chains that code for proteins that induce effects directed against viruses
03/20/2012CA2446872C Immune-modulating peptide
03/20/2012CA2444463C Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
03/20/2012CA2441292C Equine herpesvirus vaccine
03/20/2012CA2410901C Methods and compounds for controlled release of recombinant parvovirus vectors
03/20/2012CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate
03/20/2012CA2396227C 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/20/2012CA2352603C Gp120 mutants and biological applications
03/20/2012CA2334857C Interferon inducing genetically engineered attenuated viruses
03/20/2012CA2222000C Abundant extracellular products and methods for their production and use
03/17/2012CA2752396A1 Pertussis antibodies and uses thereof
03/15/2012WO2012034090A1 Compositions and methods for the removal of biofilms
03/15/2012WO2012034079A2 Macrolide dosage forms
03/15/2012WO2012034077A2 Compositions and methods related to attenuated staphylococcal strains
03/15/2012WO2012034025A2 Human cytomegalovirus vaccine
03/15/2012WO2012033952A1 3 - phenyl- 2 -oxo- 1, 3 -oxazolidines for treatment of bacterial infections
03/15/2012WO2012033911A2 Polyionic papilloma virus-like particle (vlp) vaccines
03/15/2012WO2012033858A2 Boron-containing small molecules
03/15/2012WO2012033736A1 Novel piperazine analogs as broad-spectrum influenza antivirals
03/15/2012WO2012033735A1 Inhibitors of human immunodeficiency virus replication
03/15/2012WO2012033450A1 Novel antimicrobial peptides
03/15/2012WO2012033427A1 Method for treating mycotic infections and drug for carrying out said method
03/15/2012WO2012033261A1 Pharmaceutical composition for preventing or treating sepsis, containing genipin or derivative thereof
03/15/2012WO2012033142A1 Hepatitis c virus liposome vaccine
03/15/2012WO2012032541A1 "adefovir dipivoxil pseudopolymorph"
03/15/2012WO2012032360A2 Novel use
03/15/2012WO2012032358A1 Immunogenic composition comprising neisseria menigitidis macrophage infectivity potentiator protein
03/15/2012WO2012032250A1 Method for preparing an extract of centella asiatica
03/15/2012WO2012032065A1 Indazole derivatives for use in the treatment of influenza virus infection
03/15/2012WO2012031539A1 Nucleoside derivatives, synthesis methods and uses thereof for preparing anti-tumor and anti-virus medicaments
03/15/2012WO2012031526A1 Chinese medicine composition for prevention and treatment of nephropathogenic infectious bronchitis and avian nephrosis
03/15/2012WO2012031307A1 Pleuromutilin derivatives for use in the treatment of diseases mediated by microbes
03/15/2012WO2012010938A3 Pharmaceutical composition of cefditoren pivoxil
03/15/2012WO2012009699A3 Process for preparing antiviral compounds
03/15/2012WO2011139348A3 Uses of phospholipid conjugates of synthetic tlr7 agonists
03/15/2012WO2011133729A3 Anti-viral compounds
03/15/2012WO2011121289A3 Peptides and their use
03/15/2012WO2011119716A3 Flavivirus host range mutations and uses thereof
03/15/2012WO2011100234A3 Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods
03/15/2012WO2010120365A3 Protein-carrier conjugates
03/15/2012US20120066779 Hepatitis c receptor protein cd81
03/15/2012US20120065358 Biodegradable poly(beta-amino esters) and uses thereof
03/15/2012US20120065273 Tto-based wide spectrum therapeutics, disinfectants & anesthetics for use in aquaculture
1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 1798